References
- Holick MF. Vitamin D deficiency. New Engl J Med 2007; 357:266–81.
- Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8–28.
- DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80(6 Suppl):1689–96S.
- Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, . Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86:888–94.
- Veenstra TD, Prufer K, Koenigsberger C, Brimijoin SW, Grande JP, Kumar R. 1,25–Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res 1998;804:193–205.
- Burkert R, McGrath J, Eyles D. Vitamin D receptor expression in the embryonic rat brain. Neurosci Res Communicat 2003;33:63–71.
- Brown J, Bianco JI, McGrath JJ, Eyles DW. 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Let 2003;343:139–43.
- Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003;118:641–53.
- Mackay-Sim A, Feron F, Eyles D, Burne T, McGrath J. Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol 2004;59:351–80.
- Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998;172:110–20.
- Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatr 1995;52:805–18; discussion 19–20.
- McGrath J, Selten JP, Chant D. Long-term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration – data from Australia and the Netherlands. Schizophr Res 2002;54:199–212.
- McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Järvelin MR, . Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004;67:237–45.
- Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999;3:5–7.
- Shipowick CD, Moore CB, Corbett C, Bindler R. Vitamin D and depressive symptoms in women during the winter: a pilot study. Appl Nurs Res 2009;22:221–5.
- Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008;264:599–609.
- Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology 1999;39:63–70.
- Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, . Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur J Clin Nutr 2009;63:1444–7.
- Parker G, Brotchie H. ‘D’ for depression: any role for vitamin D?: ‘Food for Thought’ II. Acta Psychiatr Scand 2011;124:243–9.
- Bertone-Johnson ER. Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev 2009;67:481–92.
- Khan A, Tupling D. A brief note on serum calcium levels in schizophrenics and controls. Can J Psychiatr 1990;35:74–6.
- Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J. Neural Transmission 2000;107:839–42.
- Wyszogrodzka-Kucharska A, Rabe-Jablonska J. Calcium balance and regulation in schizophrenic patients treated with second generation antipsychotics. Psychiatria Pol 2005;39:1157–171.
- Higuchi T, Komoda T, Sugishita M, Yamazaki J, Miura M, Sakagishi Y, . Certain neuroleptics reduce bone mineralization in schizophrenic patients. Neuropsychobiology 1987;18:185–8.